Literature DB >> 6187354

Interferon in suction blister fluid from psoriatic lesions.

J R Bjerke, J K Livden, M Degré, R Matre.   

Abstract

Interferon (IFN) (at least 16 units/ml) was demonstrated in suction blister fluid obtained from lesional skin in nine of thirteen patients with psoriasis vulgaris and in two patients with allergic contact dermatitis, but not in blister fluid from unaffected skin. IFN was detected in only three of the sera from the patients with psoriasis. The difference in results between the blister fluid and the sera from these patients was statistically significant (P less than 0.025). Evidence was obtained which indicated that the activity was probably IFN-gamma (immune IFN), but the additional presence of IFN-alpha in some of the fluids could not be excluded. The data indicate that IFN is produced locally in the psoriatic lesions, most likely by activated T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187354     DOI: 10.1111/j.1365-2133.1983.tb03967.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 3.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

4.  Modulation of granulocyte oxidative response by recombinant interferon alpha 2 and gamma.

Authors:  A Kapp; H Kirchner; H Wokalek; E Schöpf
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models.

Authors:  Johann E Gudjonsson; Jun Ding; Andrew Johnston; Trilokraj Tejasvi; Andrew M Guzman; Rajan P Nair; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2010-03-11       Impact factor: 8.551

6.  Effect of interferons (rIFN-alpha 2, rIFN-gamma) on DNA-synthesis and HLA-DR expression in psoriasis.

Authors:  H J Schulze; G Mahrle
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

7.  Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis.

Authors:  Andrew Johnston; Xianying Xing; William R Swindell; James Kochkodan; Marybeth Riblett; Rajan P Nair; Philip E Stuart; Jun Ding; John J Voorhees; James T Elder; Johann E Gudjonsson
Journal:  Hum Mol Genet       Date:  2013-01-31       Impact factor: 6.150

8.  Psoriatic science.

Authors:  B S Baker; A V Powles; L Fry; J P McFadden; L Brent; H Valdimarsson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12

9.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

10.  Cytokine expression in psoriatic skin lesions during PUVA therapy.

Authors:  A K Olaniran; B S Baker; D G Paige; J J Garioch; A V Powles; L Fry
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.